Latest Breaking News On - Director shreehas tambe - Page 1 : comparemela.com

Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions

The US Food and Drug Administration (USFDA) has approved the company s first-to-file application for Yesafili, a vascular endothelial growth factor inhibitor used to treat several different types of ophthalmology conditions, the company said in a statement.

United statesShreehas tambeBiocon biologicsDrug administrationBiocon ltdDirector shreehas tambe

Biocon Biologics completes integration of Viatris biosimilars business

Biocon Biologics completes integration of Viatris biosimilars business
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

United statesBiocon biologicsShreehas tambeViatris incNorth americaEmerging marketsDirector shreehas tambe

biocon biologics: Biocon Biologics takes over Viatris biosimilar biz in over 70 countries

Biocon Biologics on Wednesday said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July 1, 2023, increasing the scale and scope of its business. Following the deal closure in November 2022, this marks the first wave of countries where Viatris operations have fully transitioned to Biocon Biologics, the company said in a statement.

Biocon biologicsShreehas tambeViatris incBiocon ltdDirector shreehas tambe